STOCK TITAN

CRSP (NASDAQ: CRSP) holder plans Rule 144 share sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder filed a Rule 144 notice to sell 34,972 shares of common stock through Morgan Stanley Smith Barney on or about January 22, 2026 on NASDAQ. The planned sale has an aggregate market value of $2,105,069.60.

The shares to be sold were acquired on January 22, 2026 via a stock option exercise, paid for in cash. Shares of the issuer outstanding were 95,300,233 at the time of the notice; this is a baseline figure, not the amount being sold.

Over the prior three months, the same seller, Raju Prasad, reported additional common share sales of 10,000 shares for $559,548.00 on December 22, 2025 and 29,700 shares for $1,786,635.87 on January 6, 2026.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many CRSP common shares are planned for sale under this Rule 144 notice?

The Rule 144 notice covers a planned sale of 34,972 shares of common stock through Morgan Stanley Smith Barney on or about January 22, 2026.

What is the market value of the CRSP shares to be sold?

The 34,972 common shares covered by the Rule 144 notice have an aggregate market value of $2,105,069.60 based on the price indicated in the filing.

How were the CRSP shares being sold under Rule 144 acquired?

The 34,972 shares to be sold were acquired on January 22, 2026 through a stock option exercise from the issuer, with the purchase price paid in cash.

Which broker and exchange are involved in this CRSP Rule 144 sale?

The planned sale will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, and the common shares are expected to be sold on the NASDAQ exchange.

How many CRSP shares has the seller disposed of in the past three months?

In the three months before this notice, Raju Prasad reported selling 10,000 common shares for $559,548.00 on December 22, 2025 and 29,700 common shares for $1,786,635.87 on January 6, 2026.

What does this Rule 144 filing indicate about the CRSP shareholder?

The filing indicates that a shareholder, Raju Prasad, intends to sell 34,972 common shares under Rule 144 and confirms that the shareholder represents not knowing any undisclosed material adverse information about the issuer.

Crispr Therapeut

NASDAQ:CRSP

CRSP Rankings

CRSP Latest News

CRSP Latest SEC Filings

CRSP Stock Data

5.80B
93.75M
1.64%
80.94%
24.27%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
Switzerland
ZUG